Natural Capsules Board Approves FY26 Results, Re-appoints Director, Appoints CS & Internal Auditor
Natural Capsules Limited's Board approved FY26 results. Mr. Shri Laxminarayana Moondra was re-appointed Whole-time Director for 3 years. M/s. Mallya & Mallya appointed Internal Auditors, and Mr. Akshay Dutta named Company Secretary. 25,000 equity shares were allotted under ESOP, increasing share capital to ₹10,41,11,540.
The re-appointment of a director, appointment of key personnel like the Company Secretary, and approval of financial results are significant for corporate governance and operational continuity. The ESOP allotment also impacts share capital. These events are material to stakeholders.
The announcement details routine corporate actions such as board meeting outcomes, financial results, re-appointments, and new appointments, which are standard operational updates and do not inherently suggest a positive or negative shift in the company's performance or outlook.
Natural Capsules Limited announced the outcome of its Board Meeting held on May 27, 2026. The Board approved the Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2026.
The meeting also saw the approval for the re-appointment of Mr. Shri Laxminarayana Moondra as Whole-time Director for a term of 3 years, with a revision in remuneration effective July 28, 2026, subject to shareholder approval at the upcoming Annual General Meeting (AGM).
Further, M/s. Mallya & Mallya, Chartered Accountants, were appointed as Internal Auditors for the Financial Year 2026-27. Mr. Akshay Dutta was appointed as the Company Secretary & Compliance Officer, effective May 27, 2026.
The Nomination Remuneration & Compensation Committee approved the allotment of 25,000 Equity shares of face value Rs. 10 each, fully paid up, against the exercise of vested options under the Employee Stock Option Plan 2025. This allotment increased the company's paid-up share capital from ₹10,38,61,540 to ₹10,41,11,540.
The Board meeting commenced at 3:13 PM and concluded at 7:18 PM. The date and timings for the ensuing AGM will be intimated in due course.
What to do with a filing like this
Natural Capsules Limited filed this with the NSE as a statutory disclosure, categorised under board meeting. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Natural Capsules Limited. Read the original for the full detail.